Skip to content

Clinical trials

Sarcopenia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcopenia Country / region: Netherlands Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20093
20111
20122
20132
20143
20152
20181
20191
20212
20225
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center16
Wageningen University6
Radboud University Medical Center2
Amsterdam University of Applied Sciences1
Erasmus Medical Center1
Insel Gruppe AG, University Hospital Bern1
Nutricia Research1
Regeneron Pharmaceuticals1
Roessingh Research and Development1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcopenia32
Atrophy3
Muscular Atrophy3
Cachexia1
Cognitive Dysfunction1
Diabetes Mellitus1
Frailty1
Hypertrophy1
Insulin Resistance1
Kidney Failure, Chronic1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.